The promise of antiangiogenic therapy for ovarian cancer

Cancer Biol Ther. 2009 Dec;8(23):2273-4. doi: 10.4161/cbt.8.23.10414. Epub 2009 Dec 25.
No abstract available

Publication types

  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Animals
  • Female
  • Humans
  • Integrin alphaVbeta3 / antagonists & inhibitors*
  • Integrin alphaVbeta3 / genetics
  • Integrin alphaVbeta3 / metabolism
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / metabolism
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Angiogenesis Inhibitors
  • Integrin alphaVbeta3
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, mouse